Michael Saylor Warns MSTR Investors to Prepare for ‘Difficult Years’ — Hold for at Least 4 Years

Gold corrects 26% from record high | Is this a buying opportunity ahead of Diwali?

Zevra Therapeutics: Miplyffa Validates The Bull Case, Europe Still The Swing Factor

The S&P 500 is facing rate chaos and narrow breadth. Why one Goldman Sachs insider is still bullish on stocks.

Manufacturing's Skewed Upturn Starts To Broaden Out

Rising corporate borrowing costs force US companies to rethink plans